180
Participants
Start Date
August 31, 2010
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Lenalidomide
Starting dose 10 mg by mouth daily for 21 days of a 28 day cycle.
Bevacizumab
Starting dose: 5 mg/kg by vein every 2 weeks of a 28 day cycle.
Sorafenib
Starting dose: 200 mg by mouth daily for 28 a day cycle.
Temsirolimus
Starting dose: 15 mg by vein every week for a 28 day cycle.
Lenalidomide
Starting dose: 5 mg by mouth daily for 14 days of a 21 day cycle.
Oxaliplatin
Starting dose: 65 mg/m2 by vein on day 1 of a 21 day cycle.
Leucovorin
400 mg/m2 by vein on day 1 of a 21 day cycle.
5-fluorouracil
400 mg/m2 by vein through ambulatory pump on days 1-2 of a 21 day cycle.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene
INDUSTRY
M.D. Anderson Cancer Center
OTHER